STAT | A decade of reporting from the frontiers of health and medicine

Skip to Main Content

Experience STAT's journalism live at an upcoming STAT Summit

Experience STAT's journalism live at an upcoming STAT Summit

February 4, 2026

I spent nearly 20 years on a drug for restless leg syndrome. It wrecked my life
February 3, 2026

STAT Plus: FDA Commissioner Marty Makary tries to soothe staff concerns over voucher program
February 3, 2026

STAT Plus: Novo Nordisk sees lower sales, profits as Wegovy faces growing competition
February 3, 2026

STAT Plus: Pfizer moves forward with its hopes for a monthly obesity drug
February 3, 2026

From Croatia to MAHA: How an unapproved drug became the next hot peptide
February 3, 2026

We asked whether principal investigators have plans in place for how research can continue without them

Test your knowledge with our now weekday mini crossword

Play the STAT Mini

Join STAT reporters and industry leaders in NYC this March for our first summit of 2026

STAT Plus: Trump administration officials blocked FDA effort to fast-track review of psychedelic treatment

The decision suggests possible discord on a new class of therapies

Health February 3, 2026

Plastic surgeons society recommends delaying gender-affirming procedures until age 19

Health February 3, 2026

Fearing ICE crackdown, immigrants nationally are avoiding treatment, sometimes with dire consequences

Health tech February 3, 2026

STAT Plus: AI could soon renew prescriptions without clinician help. Should the FDA make sure it’s safe?

In the Lab February 4, 2026

Junior scientists face a quandary when starting their own labs: How far to stray from the hive

Sponsored

Advertisement

Sign up for Newsletters

STAT+

Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.

Cancel anytime.

STAT Plus: Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer’s

STAT Plus: A telling UnitedHealth chart, and the Medicare Advantage earthquake

STAT Plus: FDA officials push for long-term monitoring of autoimmune patients receiving CAR-T therapy

STAT Plus: FDA Commissioner Marty Makary tries to soothe staff concerns over voucher program

STAT Plus: Federal judge dismisses lawsuit against academic publishers over unpaid peer review

All STAT+ Stories

All Events

More From STAT

More From STAT

More From STAT

STAT offers a variety of in-person and virtual events throughout the year.

All Events

2026 Breakthrough Summit East

New York City, NY

Exploring the breakthroughs and R&D fueling the next generation of medical discovery.

2026 Breakthrough Summit West

San Francisco, CA

2026 STAT Summit

Boston, MA

All Events

All Trackers

More From STAT

More From STAT

More From STAT

We create tools to help you understand and track complex areas of development.

All Trackers

Obesity Drug Tracker

Here are the dozens of weight loss drugs in development to catch a booming market.

CRISPR Tracker

Follow the latest developments in genome editing.

Generative AI Tracker

A guide to the health systems and companies driving adoption.

Breakthrough Device Tracker

An authoritative database of FDA’s fast-tracked medical devices.

All Reports

More From STAT

More From STAT

More From STAT

STAT Reports blend data insights with qualitative observations on pivotal life sciences topics.

All Reports

2025 Edition: Ranking Biotech's Top Venture Capital Firms

$499

Dive into the performance of leading biotech venture capital firms and find out who got the best returns this year.

All Podcasts

More From STAT

More From STAT

More From STAT

From policy to practice: STAT's podcasts decode health care complexities.

All Podcasts

The Readout LOUD

Our weekly biotech podcast digs deep into industry goings-on.

First Opinion Podcast

A weekly interview show featuring the most interesting people and ideas in medicine.

Color Code

Enjoy the archives of Color Code, our podcast on racial inequities in American health care.

More From STAT

View upcoming events Play the STAT Mini Crossword Explore trackers Download our latest Report Listen to STAT podcasts

More Stories

First Opinion February 4, 2026

I spent nearly 20 years on a drug for restless leg syndrome. It wrecked my life

Exclusive February 3, 2026

STAT Plus: FDA Commissioner Marty Makary tries to soothe staff concerns over voucher program

Pharma February 3, 2026

STAT Plus: Novo Nordisk sees lower sales, profits as Wegovy faces growing competition

Pharma February 3, 2026

STAT Plus: Pfizer moves forward with its hopes for a monthly obesity drug

Health February 3, 2026

From Croatia to MAHA: How an unapproved drug became the next hot peptide

First Opinion February 3, 2026

We asked whether principal investigators have plans in place for how research can continue without them

First Opinion February 3, 2026

Plain language abstracts can help reduce misuse of science

Health tech February 3, 2026

STAT Plus: New data shows how HHS is implementing Trump AI mandates

Pharmalot February 3, 2026

STAT Plus: As U.S. officials move to reduce animal testing in research, focus may shift to restrictions on imports

Health February 2, 2026

What to know about Catherine O’Hara’s rare heart condition, dextrocardia

Biotech February 2, 2026

STAT Plus: FDA officials push for long-term monitoring of autoimmune patients receiving CAR-T therapy

In the Lab February 2, 2026

STAT Plus: Federal judge dismisses lawsuit against academic publishers over unpaid peer review

The Readout February 4, 2026

STAT Plus: Pfizer defends data on Metsera candidate

Pharmalot February 4, 2026

STAT Plus: Pharmalittle: We’re reading about worries over FDA voucher program, a new U.S. Novo exec, and more

Health Tech Newsletter February 3, 2026

STAT Plus: AI doctors are coming. Should FDA make sure they’re safe?

The Readout February 3, 2026

STAT Plus: Pfizer unveils data on Metsera drug

Pharmalot February 3, 2026

STAT Plus: Pharmalittle: We’re reading about a Pfizer obesity pill, Florida’s failed drug importation plan, and more

Health Care Inc. Newsletter February 2, 2026

STAT Plus: A telling UnitedHealth chart, and the Medicare Advantage earthquake

First Opinion February 4, 2026

I spent nearly 20 years on a drug for restless leg syndrome. It wrecked my life

First Opinion February 3, 2026

We asked whether principal investigators have plans in place for how research can continue without them

First Opinion February 3, 2026

Plain language abstracts can help reduce misuse of science

First Opinion February 2, 2026

The EPA just erased a century of public health progress

First Opinion February 2, 2026

How much should psychedelics researchers disclose about their personal use?

First Opinion January 31, 2026

STAT readers on shared decision-making, prostate cancer screening, and more

Newsletters

Mon - Fri

Your daily dose of news in health and science

Our Picks

Our Picks

STAT’s selection of must-read stories and investigations

American Science, Shattered: How the Trump administration has disrupted labs, upended lives, and delayed discoveries

By STAT Staff

9 influencers shaping health information online, for better or worse

Tenuous biomedical funding has put first-year Ph.D. students in a bind

By Jonathan Wosen

STAT Plus: Endometriosis often takes years to diagnose. Startups want to change that

By Theresa Gaffney

STAT Plus: How Opvee, Indivior’s powerful overdose antidote, went bust

With new vaccine schedule secured, RFK Jr. allies head to statehouses

By Daniel Payne and Isabella Cueto

STAT Plus: Behind new dietary guidelines: Industry-funded studies, opaque science, crushing deadline pressure

By Isabella Cueto

STAT Plus: ChatGPT and Claude get into the business of health advice. Should you trust them?

By Brittany Trang

STAT Plus: FDA halts gene therapy trials after brain tumor found in patient

Biotech January 28, 2026

STAT Plus: FDA halts gene therapy trials after brain tumor found in patient

Biotech January 26, 2026

STAT Plus: FDA’s new ‘plausible mechanism pathway’ for personalized gene editing raises concerns

Biotech January 20, 2026

STAT Plus: Corvus pill shows promise in early-stage eczema trial

STAT Plus: Pharmalittle: We’re reading about obesity drug sales, India’s biopharma research push, and more

Pharmalot February 2, 2026

STAT Plus: Pharmalittle: We’re reading about obesity drug sales, India’s biopharma research push, and more

Pharmalot February 2, 2026

STAT Plus: Sanofi is reprimanded by a U.K. trade group for misleading claims about a Pfizer vaccine

Pharma February 2, 2026

STAT Plus: As its immunology work draws attention, Sanofi also pushes forward in rare disease

Do mornings make cancer immunotherapy more effective? Study: Maybe

Health February 2, 2026

Do mornings make cancer immunotherapy more effective? Study: Maybe

Health February 2, 2026

As male birth control gets closer to reality, men are lining up for clinical trials

Health January 29, 2026

Genes influence human lifespan far more than thought, new study suggests

STAT Plus: New rule would force PBMs to disclose drug rebates and other fees

Politics January 30, 2026

STAT Plus: New rule would force PBMs to disclose drug rebates and other fees

Politics January 30, 2026

Newsom files a civil rights complaint against CMS’ Oz in latest feud with the Trump administration

Politics January 29, 2026

Trump’s addiction initiative brings bold rhetoric but few details

Video

How ‘gas station drugs’ remain legal

Breaking down JPM 2026: the mood, the big interviews — and all the AI billboards

Why this year’s JPM health care conference has a different vibe

STAT’s Helen Branswell on the ‘startling’ new U.S. vaccine schedule

American science, Shattered

American science, Shattered

How direct-to-consumer health tests could impact insurance, mortgages, and employment

Health tech January 30, 2026

How direct-to-consumer health tests could impact insurance, mortgages, and employment

Health tech January 28, 2026

STAT Plus: DeepMind releases AlphaGenome source code, aiming to improve its AI predictions of gene regulation

Health tech January 28, 2026

STAT Plus: Why some hospitals are making their own ChatGPTs for patient records

STAT Plus: Anthony Letai says NCI is more stable than perceived and is heading for a big year

In the Lab January 22, 2026

STAT Plus: Anthony Letai says NCI is more stable than perceived and is heading for a big year

In the Lab January 15, 2026

STAT Plus: Novo Nordisk Foundation gives $850M to nonprofit to help commercialize research in Europe

In the Lab January 15, 2026

Enrollment in biomedical degree programs rose last fall despite funding turmoil, new data show

STAT Plus: HCA expects $1 billion hit from loss of ACA tax credits, Medicaid changes

Hospitals January 27, 2026

STAT Plus: HCA expects $1 billion hit from loss of ACA tax credits, Medicaid changes

Hospitals January 25, 2026

STAT Plus: How investing in primary care helped a hospital system get back in the black

Hospitals January 22, 2026

STAT Plus: Alabama hospital system would gain monopoly with proposed $450 million deal

STAT Plus: UnitedHealth has turned Medicare Advantage coding into ‘profit-centered strategy,’ Senate report finds

Insurance January 12, 2026

STAT Plus: UnitedHealth has turned Medicare Advantage coding into ‘profit-centered strategy,’ Senate report finds

Insurance December 17, 2025

STAT Plus: After revolt from moderate Republicans, House to vote on ACA subsidy extension

Insurance December 12, 2025

STAT Plus: Medicare routes $16 billion to insurers to offset high drug costs

Podcasts

The high stakes for Huntington’s patients

Live from JPM 2026, a sit-down with Novo Nordisk’s CEO and VC Bob Nelsen

JPM to bring more deals and happy CEOs

Biotech’s year in review